{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T23:50:15Z","timestamp":1795132215306,"version":"4.10.3"},"reference-count":248,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry &amp; Cell Biology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.biocel.2018.01.003","type":"journal-article","created":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T13:13:40Z","timestamp":1515158020000},"page":"63-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":164,"special_numbering":"C","title":["Breast cancer bone metastases: pathogenesis and therapeutic targets"],"prefix":"10.1016","volume":"96","author":[{"given":"Naomi","family":"Brook","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Brook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Dharmarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crispin R.","family":"Dass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlene","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.biocel.2018.01.003_bib0005","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1016\/j.yexcr.2008.02.006","article-title":"Osteoactivin: an anabolic factor that regulates osteoblast differentiation and function","volume":"314","author":"Abdelmagid","year":"2008","journal-title":"Exp. Cell Res."},{"issue":"6","key":"10.1016\/j.biocel.2018.01.003_bib0010","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/BF02556671","article-title":"The acute-phase response after bisphosphonate administration","volume":"41","author":"Adami","year":"1987","journal-title":"Calcif. Tissue Int."},{"issue":"1","key":"10.1016\/j.biocel.2018.01.003_bib0015","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.bone.2010.10.044","article-title":"A phase II, randomized, open-label, pilot study to evaluate the safety and the effects on bone resorption of saracatinib (AZD0530) in patients with prostate cancer or breast cancer with metastatic bone disease","volume":"48","author":"Aklilu","year":"2011","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.biocel.2018.01.003_bib0020","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.bone.2010.10.044","article-title":"A phase II, randomized, open-label, pilot study to evaluate the safety and the effects on bone resorption of saracatinib (AZD0530) in patients with prostate cancer or breast cancer with metastatic bone disease","volume":"48","author":"Aklilu","year":"2011","journal-title":"Bone"},{"issue":"8","key":"10.1016\/j.biocel.2018.01.003_bib0025","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/sj.bjc.6602417","article-title":"Vascular endothelial growth factor acts as an osteolytic factor in breast cancer metastases to bone","volume":"92","author":"Aldridge","year":"2005","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.biocel.2018.01.003_bib0030","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1073\/pnas.67.3.1513","article-title":"Isolation and characterization of calcifying matrix vesicles from epiphyseal cartilage","volume":"67","author":"Ali","year":"1970","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6656","key":"10.1016\/j.biocel.2018.01.003_bib0035","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/36593","article-title":"A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function","volume":"390","author":"Anderson","year":"1997","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biocel.2018.01.003_bib0040","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1083\/jcb.41.1.59","article-title":"Vesicles associated with calcification in the matrix of epiphyseal cartilage","volume":"41","author":"Anderson","year":"1969","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.biocel.2018.01.003_bib0045","series-title":"A Study to Assess the Effects of MK0822 in Reducing the Risk of Bone Metastasis in Women With Breast Cancer (0822-029) Withdrawn","author":"Anon","year":"2015"},{"key":"10.1016\/j.biocel.2018.01.003_bib0050","series-title":"Dasatinib in Combination With Zoledronic Acid for the Treatment of Breast Cancer With Bone Metastasis","author":"Anon","year":"2016"},{"key":"10.1016\/j.biocel.2018.01.003_bib0055","series-title":"S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer","author":"Anon","year":"2017"},{"key":"10.1016\/j.biocel.2018.01.003_bib0060","series-title":"Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)","author":"Anon","year":"2017"},{"key":"10.1016\/j.biocel.2018.01.003_bib0065","series-title":"Cabozantinib in Women With Metastatic Hormone-Receptor-Positive Breast Cancer","author":"Anon","year":"2017"},{"issue":"12","key":"10.1016\/j.biocel.2018.01.003_bib0070","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1084\/jem.190.12.1741","article-title":"Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor \u03baB (RANK) receptors","volume":"190","author":"Arai","year":"1999","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.biocel.2018.01.003_bib0075","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0169-6009(89)90048-2","article-title":"A comparative electron microscopic study of apatite crystals in collagen fibrils of rat bone: dentin and calcified turkey leg tendons","volume":"6","author":"Arsenault","year":"1989","journal-title":"Bone Miner."},{"issue":"6","key":"10.1016\/j.biocel.2018.01.003_bib0080","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.bone.2007.02.024","article-title":"Metabolism of vitamin D 3 in human osteoblasts: evidence for autocrine and paracrine activities of 1\u03b1, 25-dihydroxyvitamin D 3","volume":"40","author":"Atkins","year":"2007","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.biocel.2018.01.003_bib0085","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1469-7580.1997.19110039.x","article-title":"Distribution of matrix metalloproteinases and their inhibitor, TIMP-1, in developing human osteophytic bone","volume":"191","author":"BORD","year":"1997","journal-title":"J. Anat."},{"issue":"10","key":"10.1016\/j.biocel.2018.01.003_bib0090","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1359\/jbmr.060714","article-title":"Vitamin D action and regulation of bone remodeling: suppression of osteoclastogenesis by the mature osteoblast","volume":"21","author":"Baldock","year":"2006","journal-title":"J. Bone Miner. Res."},{"issue":"13","key":"10.1016\/j.biocel.2018.01.003_bib0095","doi-asserted-by":"crossref","first-page":"6714","DOI":"10.1158\/0008-5472.CAN-05-3565","article-title":"Inhibition of pulmonary and skeletal metastasis by a transforming growth factor-\u03b2 type I receptor kinase inhibitor","volume":"66","author":"Bandyopadhyay","year":"2006","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.biocel.2018.01.003_bib0100","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/0022034510397196","article-title":"Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR dental PBRN","volume":"90","author":"Barasch","year":"2011","journal-title":"J. Dent. Res."},{"issue":"10","key":"10.1016\/j.biocel.2018.01.003_bib0105","first-page":"2631","article-title":"Osteoblast-related transcription factors Runx2 (Cbfa1\/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells","volume":"63","author":"Barnes","year":"2003","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.biocel.2018.01.003_bib0110","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1359\/JBMR.040305","article-title":"A single-dose placebo-controlled study of AMG 162: a fully human monoclonal antibody to RANKL, in postmenopausal women","volume":"19","author":"Bekker","year":"2004","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.biocel.2018.01.003_bib0115","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.bbamcr.2013.12.015","article-title":"Microenvironmental stimuli affect Endothelin-1 signaling responsible for invasiveness and osteomimicry of bone metastasis from breast cancer","volume":"1843","author":"Bendinelli","year":"2014","journal-title":"Biochim. et Biophys. Acta (BBA)-Mol. Cell Res."},{"issue":"4","key":"10.1016\/j.biocel.2018.01.003_bib0120","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1210\/endo-119-4-1776","article-title":"1, 25-Dihydroxyvitamin D3 and human bone-derived cells in vitro: effects on alkaline phosphatase, type I collagen and proliferation","volume":"119","author":"Beresford","year":"1986","journal-title":"Endocrinology"},{"issue":"11","key":"10.1016\/j.biocel.2018.01.003_bib0125","doi-asserted-by":"crossref","first-page":"e27090","DOI":"10.1371\/journal.pone.0027090","article-title":"Anti-transforming growth factor ss antibody treatment rescues bone loss and prevents breast cancer metastasis to bone","volume":"6","author":"Biswas","year":"2011","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.biocel.2018.01.003_bib0130","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1093\/annonc\/mdg367","article-title":"Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases","volume":"14","author":"Body","year":"2003","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.biocel.2018.01.003_bib0135","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1074\/jbc.271.4.2126","article-title":"Human cathepsin O2: a matrix protein-degrading cysteine protease expressed in osteoclasts functional expression of human cathepsin O2 in Spodoptera frugiperda and characterization of the enzyme","volume":"271","author":"Br\u00f6mme","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biocel.2018.01.003_bib0140","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1677\/erc.1.01307","article-title":"Osteoblast-conditioned medium promotes proliferation and sensitizes breast cancer cells to imatinib treatment","volume":"14","author":"Brama","year":"2007","journal-title":"Endocr. Relat. Cancer"},{"issue":"8","key":"10.1016\/j.biocel.2018.01.003_bib0145","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1242\/dev.128.8.1253","article-title":"Inactivation of the (\u03b2)-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development","volume":"128","author":"Brault","year":"2001","journal-title":"Development"},{"issue":"5","key":"10.1016\/j.biocel.2018.01.003_bib0150","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/ijc.23625","article-title":"Breast cancer-derived Dickkopf1 inhibits osteoblast differentiation and osteoprotegerin expression: implication for breast cancer osteolytic bone metastases","volume":"123","author":"Bu","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"18","key":"10.1016\/j.biocel.2018.01.003_bib0155","doi-asserted-by":"crossref","first-page":"8742","DOI":"10.1158\/0008-5472.CAN-06-2490","article-title":"Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer","volume":"67","author":"Buijs","year":"2007","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.biocel.2018.01.003_bib0160","first-page":"354","article-title":"Parathyroid hormone-related protein, bone metastases and hypercalcaemia of malignancy","volume":"78","author":"Bundred","year":"1996","journal-title":"Ann. R. Coll. Surg. Engl."},{"issue":"6","key":"10.1016\/j.biocel.2018.01.003_bib0165","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1084\/jem.156.6.1604","article-title":"In vitro formation of osteoclasts from long-term cultures of bone marrow mononuclear phagocytes","volume":"156","author":"Burger","year":"1982","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.biocel.2018.01.003_bib0170","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1083\/jcb.99.6.1901","article-title":"Osteoclast formation from mononuclear phagocytes: role of bone-forming cells","volume":"99","author":"Burger","year":"1984","journal-title":"J. Cell Biol."},{"issue":"16","key":"10.1016\/j.biocel.2018.01.003_bib0175","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJM199004193221603","article-title":"Immunochemical characterization of circulating parathyroid hormone\u2013related protein in patients with humoral hypercalcemia of cancer","volume":"322","author":"Burtis","year":"1990","journal-title":"New Engl. J. Med."},{"issue":"3","key":"10.1016\/j.biocel.2018.01.003_bib0180","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1172\/JCI11296","article-title":"Activated parathyroid hormone\/parathyroid hormone\u2013related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone","volume":"107","author":"Calvi","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.biocel.2018.01.003_bib0185","first-page":"1401","article-title":"Involvement of the plasmin system in dissociation of the insulin-like growth factor-binding protein complex","volume":"130","author":"Campbell","year":"1992","journal-title":"Endocrinology"},{"issue":"10","key":"10.1016\/j.biocel.2018.01.003_bib0190","doi-asserted-by":"crossref","first-page":"7169","DOI":"10.1074\/jbc.M111.292946","article-title":"Membrane estrogen signaling enhances tumorigenesis and metastatic potential of breast cancer cells via estrogen receptor-\u03b136 \u03b1ER(36)","volume":"287","author":"Chaudhri","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.biocel.2018.01.003_bib0195","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/bcr2781","article-title":"Breast cancer metastasis to the bone: mechanisms of bone loss","volume":"12","author":"Chen","year":"2010","journal-title":"Breast Cancer Res."},{"issue":"49","key":"10.1016\/j.biocel.2018.01.003_bib0200","doi-asserted-by":"crossref","first-page":"42575","DOI":"10.1074\/jbc.M111.294595","article-title":"Regulation of breast cancer-induced bone lesions by \u03b2-catenin protein signaling","volume":"286","author":"Chen","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biocel.2018.01.003_bib0205","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12967-017-1192-x","article-title":"Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers","volume":"15","author":"Chiu","year":"2017","journal-title":"J. Transl. Med."},{"issue":"40","key":"10.1016\/j.biocel.2018.01.003_bib0210","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.1038\/sj.onc.1209552","article-title":"Cited2 modulates TGF-[beta]-mediated upregulation of MMP9","volume":"25","author":"Chou","year":"2006","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.biocel.2018.01.003_bib0215","first-page":"3557","article-title":"Burden of symptoms associated with development of metastatic bone disease in patients with breast cancer","volume":"24","author":"Cleeland","year":"2016","journal-title":"Support. Care Cancer"},{"issue":"2","key":"10.1016\/j.biocel.2018.01.003_bib0220","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1210\/me.2006-0346","article-title":"Dickkopf homolog 1 mediates endothelin-1-stimulated new bone formation","volume":"21","author":"Clines","year":"2007","journal-title":"Mol. Endocrinol."},{"issue":"16","key":"10.1016\/j.biocel.2018.01.003_bib0225","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1158\/0008-5472.CAN-09-4092","article-title":"Anti\u2013placental growth factor reduces bone metastasis by blocking tumor cell engraftment and osteoclast differentiation","volume":"70","author":"Coenegrachts","year":"2010","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.biocel.2018.01.003_bib0230","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/bjc.1998.52","article-title":"Clinical course and prognostic factors following bone recurrence from breast cancer","volume":"77","author":"Coleman","year":"1998","journal-title":"Br. J. Cancer"},{"issue":"9","key":"10.1016\/j.biocel.2018.01.003_bib0235","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S1470-2045(14)70302-X","article-title":"Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01\/04) randomised open-label phase 3 trial","volume":"15","author":"Coleman","year":"2014","journal-title":"Lancet Oncol."},{"issue":"S8","key":"10.1016\/j.biocel.2018.01.003_bib0240","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G","article-title":"Skeletal complications of malignancy","volume":"80","author":"Coleman","year":"1997","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.biocel.2018.01.003_bib0245","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/ctrv.2000.0210","article-title":"Metastatic bone disease: clinical features, pathophysiology and treatment strategies","volume":"27","author":"Coleman","year":"2001","journal-title":"Cancer Treatment Rev."},{"issue":"12","key":"10.1016\/j.biocel.2018.01.003_bib0250","first-page":"2703","article-title":"Expression of platelet-derived growth factor B-chain and the platelet-derived growth factor receptor \u03b2 subunit in human breast tissue and breast carcinoma","volume":"55","author":"Coltrera","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.biocel.2018.01.003_bib0255","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.gene.2005.12.012","article-title":"NFATc1 regulation of the human \u03b23 integrin promoter in osteoclast differentiation","volume":"372","author":"Crotti","year":"2006","journal-title":"Gene"},{"issue":"6","key":"10.1016\/j.biocel.2018.01.003_bib0260","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1469-7580.2009.01158.x","article-title":"Immunohistochemical detection of estrogen receptor \u03b2 in alveolar bone cells of estradiol-treated female rats: possible direct action of estrogen on osteoclast life span","volume":"215","author":"Cruzo\u00e9-Souza","year":"2009","journal-title":"J. Anat."},{"issue":"5","key":"10.1016\/j.biocel.2018.01.003_bib0265","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.devcel.2005.03.016","article-title":"Wnt\/\u03b2-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis","volume":"8","author":"Day","year":"2005","journal-title":"Dev. Cell"},{"issue":"14","key":"10.1016\/j.biocel.2018.01.003_bib0270","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1056\/NEJM199610033351403","article-title":"Esophagitis associated with the use of alendronate","volume":"335","author":"De Groen","year":"1996","journal-title":"New Engl. J. Med."},{"issue":"15","key":"10.1016\/j.biocel.2018.01.003_bib0275","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1093\/emboj\/17.15.4456","article-title":"PU. 1 regulates both cytokine-dependent proliferation and differentiation of granulocyte\/macrophage progenitors","volume":"17","author":"DeKoter","year":"1998","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.biocel.2018.01.003_bib0280","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.cell.2006.05.012","article-title":"SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation","volume":"125","author":"Dobreva","year":"2006","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.biocel.2018.01.003_bib0285","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0092-8674(00)80257-3","article-title":"Osf2\/Cbfa1: a transcriptional activator of osteoblast differentiation","volume":"89","author":"Ducy","year":"1997","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biocel.2018.01.003_bib0290","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1023\/A:1026404227624","article-title":"Transforming growth factor \u03b21 acts as an inducer of matrix metalloproteinase expression and activity in human bone-metastasizing cancer cells","volume":"17","author":"Duivenvoorden","year":"1999","journal-title":"Clin. Exp. Metastasis"},{"issue":"2","key":"10.1016\/j.biocel.2018.01.003_bib0295","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0022-3565(24)38786-5","article-title":"Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates","volume":"296","author":"Dunford","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"9","key":"10.1016\/j.biocel.2018.01.003_bib0300","doi-asserted-by":"crossref","first-page":"e6896","DOI":"10.1371\/journal.pone.0006896","article-title":"Hypoxia and TGF-\u03b2 drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment","volume":"4","author":"Dunn","year":"2009","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.biocel.2018.01.003_bib0305","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1172\/JCI3212","article-title":"PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha (v) beta3 integrin, and phosphorylated by src kinase","volume":"102","author":"Duong","year":"1998","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.biocel.2018.01.003_bib0310","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1158\/1535-7163.MCT-14-0253","article-title":"Efficacy of a cathepsin K inhibitor in a preclinical model for prevention and treatment of breast cancer bone metastasis","volume":"13","author":"Duong","year":"2014","journal-title":"Mol. Cancer Ther."},{"issue":"10001","key":"10.1016\/j.biocel.2018.01.003_bib0315","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0140-6736(15)60908-4","article-title":"Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials","volume":"386","author":"E.B.C.T.C. Group","year":"2015","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.biocel.2018.01.003_bib0320","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s12094-014-1247-x","article-title":"Differences of osteoblastic bone metastases and osteolytic bone metastases in clinical features and molecular characteristics","volume":"17","author":"Fang","year":"2015","journal-title":"Clin. Trans. Oncol."},{"key":"10.1016\/j.biocel.2018.01.003_bib0325","first-page":"djs485","article-title":"Inhibition of breast cancer metastases by a novel inhibitor of TGF\u03b2 receptor 1","author":"Fang","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"issue":"5","key":"10.1016\/j.biocel.2018.01.003_bib0330","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"10","key":"10.1016\/j.biocel.2018.01.003_bib0335","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1200\/JCO.2008.19.2146","article-title":"Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer: breast cancer, or other neoplasms after intravenous bisphosphonates","volume":"27","author":"Fizazi","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"41","key":"10.1016\/j.biocel.2018.01.003_bib0340","doi-asserted-by":"crossref","first-page":"25742","DOI":"10.1016\/S0021-9258(18)47310-3","article-title":"Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures","volume":"269","author":"Fowlkes","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"9992","key":"10.1016\/j.biocel.2018.01.003_bib0345","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0140-6736(15)60995-3","article-title":"Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"386","author":"Gnant","year":"2015","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.biocel.2018.01.003_bib0350","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1200\/JCO.2008.20.0725","article-title":"Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer","volume":"27","author":"Goodwin","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.biocel.2018.01.003_bib0355","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/jcb.22211","article-title":"Bone sialoprotein stimulates focal adhesion-related signaling pathways: role in migration and survival of breast and prostate cancer cells","volume":"107","author":"Gordon","year":"2009","journal-title":"J. Cell. Biochem."},{"issue":"15","key":"10.1016\/j.biocel.2018.01.003_bib0360","article-title":"Denosumab versus placebo as adjuvant treatment for women with early-stage breast cancer at high risk of disease recurrence (D-CARE): an international, placebo-controlled, randomized, double-blind phase III clinical trial","volume":"31","author":"Goss","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.biocel.2018.01.003_bib0365","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1172\/JCI118947","article-title":"Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis","volume":"98","author":"Guise","year":"1996","journal-title":"J. Clin. Invest."},{"issue":"S3","key":"10.1016\/j.biocel.2018.01.003_bib0370","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/cncr.11129","article-title":"Role of endothelin-1 in osteoblastic bone metastases","volume":"97","author":"Guise","year":"2003","journal-title":"Cancer"},{"issue":"S8","key":"10.1016\/j.biocel.2018.01.003_bib0375","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1572::AID-CNCR7>3.0.CO;2-M","article-title":"Parathyroid hormone-related protein and bone metastases","volume":"80","author":"Guise","year":"1997","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.biocel.2018.01.003_bib0380","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3111\/13696998.2014.890937","article-title":"Healthcare costs associated with skeletal-related events in breast cancer patients with bone metastases","volume":"17","author":"Hagiwara","year":"2014","journal-title":"J. Med. Econ."},{"issue":"4","key":"10.1016\/j.biocel.2018.01.003_bib0385","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.canep.2014.05.005","article-title":"Incidence of bone metastases and survival after a diagnosis of bone metastases in breast cancer patients","volume":"38","author":"Harries","year":"2014","journal-title":"Cancer Epidemiol."},{"issue":"6","key":"10.1016\/j.biocel.2018.01.003_bib0390","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1468-1331.1998.560587.x","article-title":"Clinical and autopsy findings in spinal cord compression due to metastatic disease","volume":"5","author":"Helweg-Larsen","year":"1998","journal-title":"Eur. J. Neurol."},{"issue":"16","key":"10.1016\/j.biocel.2018.01.003_bib0395","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1158\/0008-5472.CAN-11-3061","article-title":"Bone-derived IGF mediates crosstalk between bone and breast cancer cells in bony metastases","volume":"72","author":"Hiraga","year":"2012","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.biocel.2018.01.003_bib0400","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1210\/endo.140.10.7034","article-title":"Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis 1","volume":"140","author":"Hofbauer","year":"1999","journal-title":"Endocrinology"},{"issue":"8","key":"10.1016\/j.biocel.2018.01.003_bib0405","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1158\/0008-5472.CAN-05-1631","article-title":"Differential functional activation of chemokine receptor CXCR4 is mediated by G proteins in breast cancer cells","volume":"66","author":"Holland","year":"2006","journal-title":"Cancer Res."},{"issue":"24","key":"10.1016\/j.biocel.2018.01.003_bib0410","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1056\/NEJM199612123352401","article-title":"Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases","volume":"335","author":"Hortobagyi","year":"1996","journal-title":"New Engl. J. Med."},{"issue":"6","key":"10.1016\/j.biocel.2018.01.003_bib0415","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1200\/JCO.1998.16.6.2038","article-title":"Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate: Protocol 19 Aredia Breast Cancer Study Group","volume":"16","author":"Hortobagyi","year":"1998","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.biocel.2018.01.003_bib0420","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1172\/JCI117370","article-title":"Expression of the murine plasma cell nucleotide pyrophosphohydrolase PC-1 is shared by human liver, bone, and cartilage cells. Regulation of PC-1 expression in osteosarcoma cells by transforming growth factor-beta","volume":"94","author":"Huang","year":"1994","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.biocel.2018.01.003_bib0425","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1359\/jbmr.060820","article-title":"Calcitonin deficiency in mice progressively results in high bone turnover","volume":"21","author":"Huebner","year":"2006","journal-title":"J. Bone Miner. Res."},{"issue":"10","key":"10.1016\/j.biocel.2018.01.003_bib0430","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/nm1096-1132","article-title":"Estrogen promotes apoptosis of murine osteoclasts mediated by TGF\u2013\u03b2","volume":"2","author":"Hughes","year":"1996","journal-title":"Nat. Med."},{"issue":"7237","key":"10.1016\/j.biocel.2018.01.003_bib0435","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature07713","article-title":"Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis","volume":"458","author":"Ishii","year":"2009","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.biocel.2018.01.003_bib0440","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1084\/jem.20101474","article-title":"Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo","volume":"207","author":"Ishii","year":"2010","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.biocel.2018.01.003_bib0445","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1158\/1541-7786.MCR-16-0081","article-title":"CITED2 modulates breast cancer metastatic ability through effects on IKK\u03b1","volume":"14","author":"Jayaraman","year":"2016","journal-title":"Mol. Cancer Res."},{"issue":"4","key":"10.1016\/j.biocel.2018.01.003_bib0450","doi-asserted-by":"crossref","first-page":"6169","DOI":"10.18632\/oncotarget.14048","article-title":"Down-regulation of CITED2 attenuates breast tumor growth, vessel formation and TGF-\u03b2-induced expression of VEGFA","volume":"8","author":"Jayaraman","year":"2017","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.biocel.2018.01.003_bib0455","first-page":"1370","article-title":"Inhibitory effects of 1\u03b1: 25-dihydroxyvitamin D3 on the G1\u2013S phase-controlling machinery","volume":"15","author":"Jensen","year":"2001","journal-title":"Mol. Endocrinol."},{"issue":"6","key":"10.1016\/j.biocel.2018.01.003_bib0460","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3816\/CBC.2010.n.059","article-title":"The cathepsin K inhibitor odanacatib suppresses bone resorption in women with breast cancer and established bone metastases: results of a 4-week, double-blind, randomized, controlled trial","volume":"10","author":"Jensen","year":"2010","journal-title":"Clin. Breast Cancer"},{"issue":"1","key":"10.1016\/j.biocel.2018.01.003_bib0465","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2407-11-29","article-title":"Incidence of bone metastases and skeletal-related events in breast cancer patients: a population-based cohort study in Denmark","volume":"11","author":"Jensen","year":"2011","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.biocel.2018.01.003_bib0470","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.bbrc.2013.12.036","article-title":"A supra-cellular model for coupling of bone resorption to formation during remodeling: lessons from two bone resorption inhibitors affecting bone formation differently","volume":"443","author":"Jensen","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.biocel.2018.01.003_bib0475","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.bone.2005.10.003","article-title":"Regulation of SDF-1 (CXCL12) production by osteoblasts; a possible mechanism for stem cell homing","volume":"38","author":"Jung","year":"2006","journal-title":"Bone"},{"issue":"27","key":"10.1016\/j.biocel.2018.01.003_bib0480","doi-asserted-by":"crossref","first-page":"24571","DOI":"10.1074\/jbc.M202561200","article-title":"Transforming growth factor-\u03b2 stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways","volume":"277","author":"K\u00e4k\u00f6nen","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.biocel.2018.01.003_bib0485","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1535-6108(03)00132-6","article-title":"A multigenic program mediating breast cancer metastasis to bone","volume":"3","author":"Kang","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biocel.2018.01.003_bib0490","first-page":"5","article-title":"Calcitonin controls bone formation by inhibiting the release of sphingosine 1-phosphate from osteoclasts","author":"Keller","year":"2014","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biocel.2018.01.003_bib0495","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1210\/me.2007-0237","article-title":"NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP)","volume":"22","author":"Kim","year":"2008","journal-title":"Mol. Endocrinol."},{"issue":"18","key":"10.1016\/j.biocel.2018.01.003_bib0500","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1158\/0008-5472.CAN-15-2614","article-title":"Calcium-Sensing receptor promotes breast cancer by stimulating intracrine actions of parathyroid Hormone\u2013related protein","volume":"76","author":"Kim","year":"2016","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.biocel.2018.01.003_bib0505","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/jcb.10567","article-title":"Vitamin D3 supports osteoclastogenesis via functional vitamin D response element of human RANKL gene promoter","volume":"89","author":"Kitazawa","year":"2003","journal-title":"J. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.biocel.2018.01.003_bib0510","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/jcp.1072","article-title":"Endothelin-1 expression in long-term cultures of fetal rat calvarial osteoblasts: regulation by BMP-7","volume":"187","author":"Kitten","year":"2001","journal-title":"Journal of Cellular Physiology"},{"issue":"1","key":"10.1016\/j.biocel.2018.01.003_bib0515","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jsbmb.2010.03.048","article-title":"The metabolism of 25-(OH) vitamin D 3 by osteoclasts and their precursors regulates the differentiation of osteoclasts","volume":"121","author":"Kogawa","year":"2010","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"15","key":"10.1016\/j.biocel.2018.01.003_bib0520","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1200\/JCO.2005.05.116","article-title":"Zoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer: a randomized, placebo-controlled trial","volume":"23","author":"Kohno","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.biocel.2018.01.003_bib0525","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0092-8674(00)80258-5","article-title":"Targeted disruption of Cbfa1results in a complete lack of bone formation owing to maturational arrest of osteoblasts","volume":"89","author":"Komori","year":"1997","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.biocel.2018.01.003_bib0530","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0092-8674(01)00206-9","article-title":"Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man","volume":"104","author":"Kornak","year":"2001","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.biocel.2018.01.003_bib0535","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/nm.1943","article-title":"Imaging transforming growth factor-\u03b2 signaling dynamics and therapeutic response in breast cancer bone metastasis","volume":"15","author":"Korpal","year":"2009","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.biocel.2018.01.003_bib0540","first-page":"719","article-title":"Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity","volume":"104","author":"Kousteni","year":"2001","journal-title":"Cell"},{"issue":"5594","key":"10.1016\/j.biocel.2018.01.003_bib0545","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.1074935","article-title":"Reversal of bone loss in mice by nongenotropic signaling of sex steroids","volume":"298","author":"Kousteni","year":"2002","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.biocel.2018.01.003_bib0550","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jbo.2013.09.001","article-title":"Incidence: consequences and treatment of bone metastases in breast cancer patients\u2013experience from a single cancer centre","volume":"2","author":"Kuchuk","year":"2013","journal-title":"Journal of Bone Oncology"},{"issue":"2","key":"10.1016\/j.biocel.2018.01.003_bib0555","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.bbrc.2005.07.092","article-title":"The hematopoietic transcription factor PU: 1 regulates RANK gene expression in myeloid progenitors","volume":"335","author":"Kwon","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.biocel.2018.01.003_bib0560","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/2193-1801-3-328","article-title":"Health resource utilization associated with skeletal-related events in patients with advanced breast cancer: results from a prospective, multinational observational study","volume":"3","author":"L\u00fcftner","year":"2014","journal-title":"SpringerPlus"},{"issue":"4","key":"10.1016\/j.biocel.2018.01.003_bib0565","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/ijc.24780","article-title":"Identification of prospective factors promoting osteotropism in breast cancer: a potential role for CITED2","volume":"126","author":"Lau","year":"2010","journal-title":"Int. J. Cancer"},{"issue":"7","key":"10.1016\/j.biocel.2018.01.003_bib0570","doi-asserted-by":"crossref","first-page":"e66752","DOI":"10.1371\/journal.pone.0066752","article-title":"Enpp1: a potential facilitator of breast cancer bone metastasis","volume":"8","author":"Lau","year":"2013","journal-title":"PLoS One"},{"issue":"20","key":"10.1016\/j.biocel.2018.01.003_bib0575","doi-asserted-by":"crossref","first-page":"9894","DOI":"10.1158\/0008-5472.CAN-06-3940","article-title":"A Cathepsin K inhibitor reduces breast cancer\u2013induced osteolysis and skeletal tumor burden","volume":"67","author":"Le Gall","year":"2007","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.biocel.2018.01.003_bib0580","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0959-8049(00)00363-4","article-title":"A matrix metalloproteinase inhibitor: batimastat, retards the development of osteolytic bone metastases by MDA-MB-231 human breast cancer cells in Balb C nu\/nu mice","volume":"37","author":"Lee","year":"2001","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"10.1016\/j.biocel.2018.01.003_bib0585","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1083\/jcb.200409115","article-title":"Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors","volume":"169","author":"Lee","year":"2005","journal-title":"J. Cell Biol."},{"issue":"4","key":"10.1016\/j.biocel.2018.01.003_bib0590","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbrc.2009.07.029","article-title":"Identification of CITED2 as a negative regulator of fracture healing","volume":"387","author":"Lee","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.biocel.2018.01.003_bib0595","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4143\/crt.2011.43.2.89","article-title":"Implications of bone-only metastases in breast cancer: favorable preference with excellent outcomes of hormone receptor positive breast cancer","volume":"43","author":"Lee","year":"2011","journal-title":"Cancer Research and Treatment"},{"issue":"5","key":"10.1016\/j.biocel.2018.01.003_bib0600","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0026-895X(24)12222-5","article-title":"Further insight into mechanism of action of clodronate: inhibition of mitochondrial ADP\/ATP translocase by a nonhydrolyzable, adenine-containing metabolite","volume":"61","author":"Lehenkari","year":"2002","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.biocel.2018.01.003_bib0605","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.bone.2011.06.014","article-title":"The effects of the cathepsin K inhibitor odanacatib on osteoclastic bone resorption and vesicular trafficking","volume":"49","author":"Leung","year":"2011","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.biocel.2018.01.003_bib0610","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1158\/1078-0432.306.11.1","article-title":"Inhibition of platelet-derived growth factor receptor signaling restricts the growth of human breast cancer in the bone of nude mice","volume":"11","author":"Lev","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.biocel.2018.01.003_bib0615","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1056\/NEJM199508103330607","article-title":"Endothelins","volume":"333","author":"Levin","year":"1995","journal-title":"New Engl. J. Med."},{"issue":"45","key":"10.1016\/j.biocel.2018.01.003_bib0620","doi-asserted-by":"crossref","first-page":"33098","DOI":"10.1074\/jbc.M611781200","article-title":"Parathyroid hormone stimulates osteoblastic expression of MCP-1 to recruit and increase the fusion of pre\/osteoclasts","volume":"282","author":"Li","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.biocel.2018.01.003_bib0625","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1172\/JCI46134","article-title":"PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target","volume":"121","author":"Li","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.biocel.2018.01.003_bib0630","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13058-015-0537-8","article-title":"Genetic depletion and pharmacological targeting of \u03b1v integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models","volume":"17","author":"Li","year":"2015","journal-title":"Breast Cancer Res."},{"issue":"5","key":"10.1016\/j.biocel.2018.01.003_bib0635","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1082::AID-CNCR20>3.0.CO;2-Z","article-title":"Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases","volume":"88","author":"Lipton","year":"2000","journal-title":"Cancer"},{"issue":"28","key":"10.1016\/j.biocel.2018.01.003_bib0640","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1200\/JCO.2007.11.8604","article-title":"Randomized active-controlled phase II study of denosumab efficacy and safety in patients with breast cancer-related bone metastases","volume":"25","author":"Lipton","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"23","key":"10.1016\/j.biocel.2018.01.003_bib0645","first-page":"5386","article-title":"The osteoclast-associated protease cathepsin K is expressed in human breast carcinoma","volume":"57","author":"Littlewood-Evans","year":"1997","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.biocel.2018.01.003_bib0650","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.3892\/mmr.2016.5374","article-title":"Immunolocalization of MMP9 and MMP2 in osteolytic metastasis originating from MDA-MB-231 human breast cancer cells","volume":"14","author":"Liu","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biocel.2018.01.003_bib0655","series-title":"PD01-02: Randomized Phase II Study of Dasatinib Vs Placebo in Addition to Exemestane in Advanced ER\/PR-Positive Breast Cancer [BMS CA180-261 Study]","author":"Llombart","year":"2011"},{"issue":"2","key":"10.1016\/j.biocel.2018.01.003_bib0660","first-page":"666","article-title":"Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation","volume":"123","author":"Lotinun","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.biocel.2018.01.003_bib0665","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1359\/jbmr.1998.13.4.581","article-title":"Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins: including Ras","volume":"13","author":"Luckman","year":"1998","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.biocel.2018.01.003_bib0670","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/excr.1995.1005","article-title":"The influence of type I collagen on the development and maintenance of the osteoblast phenotype in primary and passaged rat calvarial osteoblasts: modification of expression of genes supporting cell growth, adhesion, and extracellular matrix mineralization","volume":"216","author":"Lynch","year":"1995","journal-title":"Exp. Cell Res."},{"issue":"16","key":"10.1016\/j.biocel.2018.01.003_bib0675","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.1073\/pnas.0401602101","article-title":"The immunomodulatory adapter proteins DAP12 and Fc receptor \u03b3-chain (FcR\u03b3) regulate development of functional osteoclasts through the Syk tyrosine kinase","volume":"101","author":"M\u00f3csai","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6824","key":"10.1016\/j.biocel.2018.01.003_bib0680","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/35065016","article-title":"Involvement of chemokine receptors in breast cancer metastasis","volume":"410","author":"M\u00fcller","year":"2001","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.biocel.2018.01.003_bib0685","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1172\/JCI26772","article-title":"Placental growth factor mediates mesenchymal cell development: cartilage turnover, and bone remodeling during fracture repair","volume":"116","author":"Maes","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.biocel.2018.01.003_bib0690","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1681\/ASN.V1261164","article-title":"Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate","volume":"12","author":"Markowitz","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.biocel.2018.01.003_bib0695","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1523-1755.2003.00071.x","article-title":"Toxic acute tubular necrosis following treatment with zoledronate (Zometa)","volume":"64","author":"Markowitz","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.biocel.2018.01.003_bib0700","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3389\/fphys.2016.00280","article-title":"Prevention of bone loss in a model of postmenopausal osteoporosis through adrenomedullin inhibition","volume":"7","author":"Mart\u00ednez-Herrero","year":"2016","journal-title":"Front. Physiol."},{"issue":"11","key":"10.1016\/j.biocel.2018.01.003_bib0705","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"12","key":"10.1016\/j.biocel.2018.01.003_bib0710","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1111\/cas.13081","article-title":"CITED2 in breast carcinoma as a potent prognostic predictor associated with proliferation: migration and chemoresistance","volume":"107","author":"Minemura","year":"2016","journal-title":"Cancer Sci."},{"issue":"23","key":"10.1016\/j.biocel.2018.01.003_bib0715","doi-asserted-by":"crossref","first-page":"5706","DOI":"10.1158\/1078-0432.CCR-15-2845","article-title":"TBCRC-010: phase I\/II study of dasatinib in combination with zoledronic acid for the treatment of Breast cancer bone metastasis","volume":"22","author":"Mitri","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.biocel.2018.01.003_bib0720","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1006\/dbio.1998.9197","article-title":"A BMP-inducible gene: dlx5, regulates osteoblast differentiation and mesoderm induction","volume":"208","author":"Miyama","year":"1999","journal-title":"Dev. Biol."},{"issue":"4","key":"10.1016\/j.biocel.2018.01.003_bib0725","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/jbmr.5650100416","article-title":"Expression and regulation of Na-Dependent pi transport in matrix vesicles produced by osteoblast-like cells","volume":"10","author":"Montessuit","year":"1995","journal-title":"J. Bone Miner. Res."},{"issue":"12","key":"10.1016\/j.biocel.2018.01.003_bib0730","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1172\/JCI0215234","article-title":"Blockade of TGF-\u03b2 inhibits mammary tumor cell viability: migration, and metastases","volume":"109","author":"Muraoka","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"16","key":"10.1016\/j.biocel.2018.01.003_bib0735","first-page":"5028","article-title":"C-SRC tyrosine kinase activity is associated with tumor colonization in bone and lung in an animal model of human breast cancer metastasis","volume":"63","author":"Myoui","year":"2003","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.biocel.2018.01.003_bib0740","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1006\/bbrc.1998.9788","article-title":"RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis","volume":"253","author":"Nakagawa","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.biocel.2018.01.003_bib0745","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0092-8674(01)00622-5","article-title":"The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation","volume":"108","author":"Nakashima","year":"2002","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.biocel.2018.01.003_bib0750","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1158\/0008-5472.CAN-09-3251","article-title":"Matrix metalloproteinase (MMP)-13 regulates mammary Tumor\u2013induced osteolysis by activating MMP9 and transforming growth factor-\u03b2 signaling at the tumor-bone interface","volume":"70","author":"Nannuru","year":"2010","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.biocel.2018.01.003_bib0755","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1038\/nm.2489","article-title":"Suppression of bone formation by osteoclastic expression of semaphorin 4D","volume":"17","author":"Negishi-Koga","year":"2011","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.biocel.2018.01.003_bib0760","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00441-010-1086-1","article-title":"Osteoblast physiology in normal and pathological conditions","volume":"343","author":"Neve","year":"2011","journal-title":"Cell Tissue Res."},{"issue":"1","key":"10.1016\/j.biocel.2018.01.003_bib0765","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/cas.12309","article-title":"Downregulation of miR-106b induced breast cancer cell invasion and motility in association with overexpression of matrix metalloproteinase 2","volume":"105","author":"Ni","year":"2014","journal-title":"Cancer Sci."},{"issue":"7","key":"10.1016\/j.biocel.2018.01.003_bib0770","doi-asserted-by":"crossref","first-page":"e39871","DOI":"10.1371\/journal.pone.0039871","article-title":"Monocytes induce STAT3 activation in human mesenchymal stem cells to promote osteoblast formation","volume":"7","author":"Nicolaidou","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.biocel.2018.01.003_bib0775","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1084\/jem.190.2.293","article-title":"Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption","volume":"190","author":"Niida","year":"1999","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.biocel.2018.01.003_bib0780","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1530\/ERC-13-0158","article-title":"Different molecular profiles are associated with breast cancer cell homing compared with colonisation of bone: evidence using a novel bone-seeking cell line","volume":"21","author":"Nutter","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"issue":"8","key":"10.1016\/j.biocel.2018.01.003_bib0785","doi-asserted-by":"crossref","first-page":"e2942","DOI":"10.1371\/journal.pone.0002942","article-title":"Control of bone mass and remodeling by PTH receptor signaling in osteocytes","volume":"3","author":"O'Brien","year":"2008","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.biocel.2018.01.003_bib0790","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1038\/sj.bjc.6601397","article-title":"Tissue and plasma expression of the angiogenic peptide adrenomedullin in breast cancer","volume":"89","author":"Oehler","year":"2003","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.biocel.2018.01.003_bib0795","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0006-291X(02)02937-6","article-title":"Role of prostaglandin E produced by osteoblasts in osteolysis due to bone metastasis","volume":"300","author":"Ohshiba","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.biocel.2018.01.003_bib0800","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1158\/0008-5472.CAN-09-3194","article-title":"Vitamin D deficiency promotes human breast cancer growth in a murine model of bone metastasis","volume":"70","author":"Ooi","year":"2010","journal-title":"Cancer Res."},{"issue":"15","key":"10.1016\/j.biocel.2018.01.003_bib0805","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1242\/jcs.110.15.1767","article-title":"Endocytic pathway from the basal plasma membrane to the ruffled border membrane in bone-resorbing osteoclasts","volume":"110","author":"Palokangas","year":"1997","journal-title":"J. Cell Sci."},{"issue":"4","key":"10.1016\/j.biocel.2018.01.003_bib0810","first-page":"1157","article-title":"Pain outcomes in patients with bone metastases from advanced cancer: assessment and management with bone-targeting agents","volume":"23","author":"Patrick","year":"2015","journal-title":"Support. Care Cancer"},{"issue":"52","key":"10.1016\/j.biocel.2018.01.003_bib0815","doi-asserted-by":"crossref","first-page":"20764","DOI":"10.1073\/pnas.0805133106","article-title":"Regulation of bone formation by osteoclasts involves Wnt\/BMP signaling and the chemokine sphingosine-1-phosphate","volume":"105","author":"Pederson","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.biocel.2018.01.003_bib0820","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10549-008-9900-0","article-title":"25-Hydroxyvitamin D3 is a natural chemopreventive agent against carcinogen induced precancerous lesions in mouse mammary gland organ culture","volume":"113","author":"Peng","year":"2009","journal-title":"Breast Cancer Res. Treat."},{"issue":"5","key":"10.1016\/j.biocel.2018.01.003_bib0825","doi-asserted-by":"crossref","first-page":"R105","DOI":"10.1186\/bcr3047","article-title":"MMP-13 stimulates osteoclast differentiation and activation in tumour breast bone metastases","volume":"13","author":"Pivetta","year":"2011","journal-title":"Breast Cancer Res."},{"issue":"3","key":"10.1016\/j.biocel.2018.01.003_bib0830","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.2353\/ajpath.2009.080906","article-title":"Bone marrow-derived cathepsin K cleaves SPARC in bone metastasis","volume":"175","author":"Podgorski","year":"2009","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.biocel.2018.01.003_bib0835","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.3892\/ol.2016.5236","article-title":"Cadherin-11 expression is upregulated in invasive human breast cancer","volume":"12","author":"Pohlodek","year":"2016","journal-title":"Oncol. Lett."},{"issue":"19","key":"10.1016\/j.biocel.2018.01.003_bib0840","doi-asserted-by":"crossref","first-page":"8581","DOI":"10.1128\/MCB.25.19.8581-8591.2005","article-title":"The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion","volume":"25","author":"Pratap","year":"2005","journal-title":"Mol. Cell. Biol."},{"issue":"19","key":"10.1016\/j.biocel.2018.01.003_bib0845","doi-asserted-by":"crossref","first-page":"7795","DOI":"10.1158\/0008-5472.CAN-08-1078","article-title":"Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells","volume":"68","author":"Pratap","year":"2008","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.biocel.2018.01.003_bib0850","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1186\/bcr3616","article-title":"Dickkopf-1 is regulated by the mevalonate pathway in breast cancer","volume":"16","author":"Rachner","year":"2014","journal-title":"Breast Cancer Res."},{"issue":"6","key":"10.1016\/j.biocel.2018.01.003_bib0855","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cmet.2010.05.005","article-title":"Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor","volume":"11","author":"Rauch","year":"2010","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.biocel.2018.01.003_bib0860","first-page":"761","article-title":"Inhibition of CXCR4 by CTCE-9908 inhibits breast cancer metastasis to lung and bone","volume":"21","author":"Richert","year":"2009","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.biocel.2018.01.003_bib0865","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1210\/edrv.23.3.0465","article-title":"Sex steroids and the construction and conservation of the adult skeleton","volume":"23","author":"Riggs","year":"2002","journal-title":"Endocr. Rev."},{"issue":"1","key":"10.1016\/j.biocel.2018.01.003_bib0870","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1042\/bj3030303","article-title":"Incorporation of bisphosphonates into adenine nucleotides by amoebae of the cellular slime mould Dictyostelium discoideum","volume":"303","author":"Rogers","year":"1994","journal-title":"Biochem. J"},{"issue":"10","key":"10.1016\/j.biocel.2018.01.003_bib0875","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1158\/1541-7786.MCR-07-0119","article-title":"Osteoactivin promotes breast cancer metastasis to bone","volume":"5","author":"Rose","year":"2007","journal-title":"Mol. Cancer Res."},{"issue":"12","key":"10.1016\/j.biocel.2018.01.003_bib0880","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/cncr.20308","article-title":"Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors","volume":"100","author":"Rosen","year":"2004","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.biocel.2018.01.003_bib0885","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/jpet.106.102004","article-title":"Inhibition of protein kinase c-Src reduces the incidence of breast cancer metastases and increases survival in mice: implications for therapy","volume":"318","author":"Rucci","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"15","key":"10.1016\/j.biocel.2018.01.003_bib0890","doi-asserted-by":"crossref","first-page":"6150","DOI":"10.1158\/0008-5472.CAN-09-2758","article-title":"Receptor activator of NF-\u03baB ligand enhances breast cancer\u2013induced osteolytic lesions through upregulation of extracellular matrix metalloproteinase inducer\/CD147","volume":"70","author":"Rucci","year":"2010","journal-title":"Cancer Res."},{"issue":"24","key":"10.1016\/j.biocel.2018.01.003_bib0895","doi-asserted-by":"crossref","first-page":"5840","DOI":"10.1038\/sj.emboj.7601430","article-title":"Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast\u2013osteoblast coupling","volume":"25","author":"Ryu","year":"2006","journal-title":"EMBO J."},{"issue":"12","key":"10.1016\/j.biocel.2018.01.003_bib0900","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/j.yexcr.2009.03.003","article-title":"Extracellular calcium promotes the migration of breast cancer cells through the activation of the calcium sensing receptor","volume":"315","author":"Saidak","year":"2009","journal-title":"Exp. Cell Res."},{"issue":"11","key":"10.1016\/j.biocel.2018.01.003_bib0905","doi-asserted-by":"crossref","first-page":"6903","DOI":"10.1074\/jbc.M114.621219","article-title":"Wnt\/\u03b2-catenin signaling mediates osteoblast differentiation triggered by peptide-induced \u03b15\u03b21 integrin priming in mesenchymal skeletal cells","volume":"290","author":"Saidak","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.biocel.2018.01.003_bib0910","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2353\/ajpath.2008.080243","article-title":"Dlx5: a positive regulator of osteoblastogenesis, is essential for osteoblast-osteoclast coupling","volume":"173","author":"Samee","year":"2008","journal-title":"Am. J. Pathol."},{"issue":"10","key":"10.1016\/j.biocel.2018.01.003_bib0915","doi-asserted-by":"crossref","first-page":"e3537","DOI":"10.1371\/journal.pone.0003537","article-title":"Osteoclasts control osteoblast chemotaxis via PDGF-BB\/PDGF receptor beta signaling","volume":"3","author":"Sanchez-Fernandez","year":"2008","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biocel.2018.01.003_bib0920","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/PL00008242","article-title":"Expression of major bone extracellular matrix proteins during embryonic osteogenesis in rat mandibles","volume":"202","author":"Sasano","year":"2000","journal-title":"Anat. Embryol. (Berl.)"},{"issue":"1","key":"10.1016\/j.biocel.2018.01.003_bib0925","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10549-016-3911-z","article-title":"Phase II studies of two different schedules of dasatinib in bone metastasis predominant metastatic breast cancer: SWOG S0622","volume":"159","author":"Schott","year":"2016","journal-title":"Breast Cancer Res. Treat."},{"issue":"5178","key":"10.1016\/j.biocel.2018.01.003_bib0930","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1126\/science.8079170","article-title":"Requirement of transcription factor PU: 1 in the development of multiple hematopoietic lineages","volume":"265","author":"Scott","year":"1994","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.biocel.2018.01.003_bib0935","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/(SICI)1097-4644(19990201)72:2<251::AID-JCB9>3.0.CO;2-W","article-title":"Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors","volume":"72","author":"Shalhoub","year":"1999","journal-title":"J. Cell. Biochem."},{"issue":"14","key":"10.1016\/j.biocel.2018.01.003_bib0940","doi-asserted-by":"crossref","first-page":"7829","DOI":"10.1073\/pnas.130200197","article-title":"Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression","volume":"97","author":"Shevde","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.biocel.2018.01.003_bib0945","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.gene.2004.08.009","article-title":"YY1 is involved in RANKL-induced transcription of the tartrate-resistant acid phosphatase gene in osteoclast differentiation","volume":"343","author":"Shi","year":"2004","journal-title":"Gene"},{"issue":"6","key":"10.1016\/j.biocel.2018.01.003_bib0950","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1186\/s13058-014-0458-y","article-title":"Tumor-expressed adrenomedullin accelerates breast cancer bone metastasis","volume":"16","author":"Siclari","year":"2014","journal-title":"Breast Cancer Res.: BCR"},{"issue":"12","key":"10.1016\/j.biocel.2018.01.003_bib0955","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1096\/fasebj.4.12.2168326","article-title":"Cellular signaling by peptides of the endothelin gene family","volume":"4","author":"Simonson","year":"1990","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.biocel.2018.01.003_bib0960","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1172\/JCI19872","article-title":"Glycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathways","volume":"113","author":"Sims","year":"2004","journal-title":"J. Clin. Invest."},{"issue":"26","key":"10.1016\/j.biocel.2018.01.003_bib0965","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1038\/sj.onc.1210154","article-title":"COX-2 involvement in breast cancer metastasis to bone","volume":"26","author":"Singh","year":"2007","journal-title":"Oncogene"},{"issue":"14","key":"10.1016\/j.biocel.2018.01.003_bib0970","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/j.febslet.2009.06.047","article-title":"Regulatory mechanism of NFATc1 in RANKL\u2010induced osteoclast activation","volume":"583","author":"Song","year":"2009","journal-title":"FEBS Lett."},{"issue":"7","key":"10.1016\/j.biocel.2018.01.003_bib0975","doi-asserted-by":"crossref","first-page":"2028S","DOI":"10.1093\/jn\/125.suppl_7.2028S","article-title":"Endothelin receptors, second messengers, and actions in bone","volume":"125","author":"Stern","year":"1995","journal-title":"J. Nutr."},{"key":"10.1016\/j.biocel.2018.01.003_bib0980","first-page":"1779","article-title":"Hypercalcemia of malignancy and new treatment options","volume":"11","author":"Sternlicht","year":"2015","journal-title":"Ther. Clin. Risk Manage."},{"issue":"35","key":"10.1016\/j.biocel.2018.01.003_bib0985","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1200\/JCO.2010.29.7101","article-title":"Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study","volume":"28","author":"Stopeck","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.biocel.2018.01.003_bib0990","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1210\/me.2007-0363","article-title":"Semaphorin 3B is a 1: 25-Dihydroxyvitamin D3-induced gene in osteoblasts that promotes osteoclastogenesis and induces osteopenia in mice","volume":"22","author":"Sutton","year":"2008","journal-title":"Mol. Endocrinol."},{"issue":"48","key":"10.1016\/j.biocel.2018.01.003_bib0995","doi-asserted-by":"crossref","first-page":"79032","DOI":"10.18632\/oncotarget.12593","article-title":"Antagonizing miR-218-5p attenuates Wnt signaling and reduces metastatic bone disease of triple negative breast cancer cells","volume":"7","author":"Taipaleenm\u00e4ki","year":"2016","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.biocel.2018.01.003_bib1000","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","article-title":"Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts","volume":"3","author":"Takayanagi","year":"2002","journal-title":"Dev. Cell"},{"issue":"4","key":"10.1016\/j.biocel.2018.01.003_bib1005","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/jbmr.1820","article-title":"EphrinB2\/EphB4 inhibition in the osteoblast lineage modifies the anabolic response to parathyroid hormone","volume":"28","author":"Takyar","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.biocel.2018.01.003_bib1010","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.33.1.17","article-title":"Cadherin-11-mediated interactions with bone marrow stromal\/osteoblastic cells support selective colonization of breast cancer cells in bone","author":"Tamura","year":"2008","journal-title":"Int. J. Oncol."},{"issue":"48","key":"10.1016\/j.biocel.2018.01.003_bib1015","doi-asserted-by":"crossref","first-page":"79688","DOI":"10.18632\/oncotarget.12939","article-title":"Breast cancer cells obtain an osteomimetic feature via epithelial-mesenchymal transition that have undergone BMP2\/RUNX2 signaling pathway induction","volume":"7","author":"Tan","year":"2016","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.biocel.2018.01.003_bib1020","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nm.1979","article-title":"TGF-\u03b21\u2013induced migration of bone mesenchymal stem cells couples bone resorption with formation","volume":"15","author":"Tang","year":"2009","journal-title":"Nat. Med."},{"issue":"38","key":"10.1016\/j.biocel.2018.01.003_bib1025","doi-asserted-by":"crossref","first-page":"32995","DOI":"10.1074\/jbc.M111.244236","article-title":"Osteoblast-specific transcription factor Osterix (Osx) is an upstream regulator of Satb2 during bone formation","volume":"286","author":"Tang","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biocel.2018.01.003_bib1030","doi-asserted-by":"crossref","first-page":"e29862","DOI":"10.1371\/journal.pone.0029862","article-title":"An osteoblast-derived proteinase controls tumor cell survival via TGF-beta activation in the bone microenvironment","volume":"7","author":"Thiolloy","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.biocel.2018.01.003_bib1035","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1210\/endo.140.10.7037","article-title":"Breast cancer cells interact with osteoblasts to support osteoclast formation 1","volume":"140","author":"Thomas","year":"1999","journal-title":"Endocrinology"},{"issue":"6620","key":"10.1016\/j.biocel.2018.01.003_bib1040","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/386081a0","article-title":"Osteopetrosis in mice lacking haematopoietic transcription factor PU . 1","volume":"386","author":"Tondravi","year":"1997","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.biocel.2018.01.003_bib1045","doi-asserted-by":"crossref","first-page":"22023","DOI":"10.1074\/jbc.M302436200","article-title":"From lysosomes to the plasma membrane localization of vacuolar type H+\u2212ATPase with the a3 isoform during osteoclast differentiation","volume":"278","author":"Toyomura","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"16","key":"10.1016\/j.biocel.2018.01.003_bib1050","doi-asserted-by":"crossref","first-page":"26687","DOI":"10.18632\/oncotarget.15803","article-title":"The vitamin D receptor is involved in the regulation of human breast cancer cell growth via a ligand-independent function in cytoplasm","volume":"8","author":"Trivedi","year":"2017","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.biocel.2018.01.003_bib1055","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/jbmr.2485","article-title":"The effects of androgens on murine cortical bone do not require AR or ER\u03b1 signaling in osteoblasts and osteoclasts","volume":"30","author":"Ucer","year":"2015","journal-title":"J. Bone Miner. Res."},{"issue":"9","key":"10.1016\/j.biocel.2018.01.003_bib1060","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1200\/JCO.2010.32.5209","article-title":"American Society of Clinical Oncology executive summary of the clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancer","volume":"29","author":"Van Poznak","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.biocel.2018.01.003_bib1065","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S8756-3282(02)00847-5","article-title":"Morphological: histomorphometric, and microstructural alterations in human bone metastasis from breast carcinoma","volume":"31","author":"Vukmirovic-Popovic","year":"2002","journal-title":"Bone"},{"issue":"12","key":"10.1016\/j.biocel.2018.01.003_bib1070","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1359\/jbmr.080706","article-title":"Cardiotrophin-1 is an osteoclast-derived stimulus of bone formation required for normal bone remodeling","volume":"23","author":"Walker","year":"2008","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.biocel.2018.01.003_bib1075","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1172\/JCI40568","article-title":"Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice","volume":"120","author":"Walker","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.biocel.2018.01.003_bib1080","doi-asserted-by":"crossref","first-page":"e62936","DOI":"10.1371\/journal.pone.0062936","article-title":"BSP gene silencing inhibits migration, invasion, and bone metastasis of MDA-MB-231BO human breast cancer cells","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.biocel.2018.01.003_bib1085","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1080\/01635581.2016.1213868","article-title":"1\u03b1: 25-Dihydroxyvitamin D inhibits the metastatic capability of MCF10CA1a and MDA-MB-231cells in an in vitro model of breast to bone metastasis","volume":"68","author":"Wilmanski","year":"2016","journal-title":"Nutr. Cancer"},{"issue":"2","key":"10.1016\/j.biocel.2018.01.003_bib1090","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1023\/A:1022943127689","article-title":"Estradiol enhances osteolytic lesions in mice inoculated with human estrogen receptor-negative MDA-231 breast cancer cells in vivo","volume":"78","author":"Winding","year":"2003","journal-title":"Breast Cancer Res. Treat."},{"issue":"7","key":"10.1016\/j.biocel.2018.01.003_bib1095","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/leu.2012.17","article-title":"Hematopoietic stem cell mobilizing agents G-CSF: cyclophosphamide or AMD3100 have distinct mechanisms of action on bone marrow HSC niches and bone formation","volume":"26","author":"Winkler","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.biocel.2018.01.003_bib1100","series-title":"Bisphosphonates and Other Bone Agents for Breast Cancer","author":"Wong","year":"2012"},{"issue":"7","key":"10.1016\/j.biocel.2018.01.003_bib1105","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/ijc.21865","article-title":"The vascular endothelial growth factor receptor (VEGFR-1) supports growth and survival of human breast carcinoma","volume":"119","author":"Wu","year":"2006","journal-title":"Int. J. Cancer"},{"issue":"7","key":"10.1016\/j.biocel.2018.01.003_bib1110","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/nm.2793","article-title":"Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells","volume":"18","author":"Xian","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.biocel.2018.01.003_bib1115","doi-asserted-by":"crossref","first-page":"32804","DOI":"10.1038\/srep32804","article-title":"CD147\/EMMPRIN overexpression and prognosis in cancer: a systematic review and meta-analysis","volume":"6","author":"Xin","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biocel.2018.01.003_bib1120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4248\/BR201301003","article-title":"Osteoclasts: new insights","volume":"1","author":"Xu","year":"2013","journal-title":"Bone. Res."},{"issue":"5","key":"10.1016\/j.biocel.2018.01.003_bib1125","doi-asserted-by":"crossref","first-page":"e37624","DOI":"10.1371\/journal.pone.0037624","article-title":"Expression of dickkopf-1 and beta-catenin related to the prognosis of breast cancer patients with triple negative phenotype","volume":"7","author":"Xu","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.biocel.2018.01.003_bib1130","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1359\/jbmr.070401","article-title":"Induction of DC\u2010STAMP by alternative activation and downstream signaling mechanisms","volume":"22","author":"Yagi","year":"2007","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.biocel.2018.01.003_bib1135","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S8756-3282(98)00138-0","article-title":"Study of immunoelectron microscopic localization of cathepsin K in osteoclasts and other bone cells in the mouse femur","volume":"23","author":"Yamaza","year":"1998","journal-title":"Bone"},{"issue":"6163","key":"10.1016\/j.biocel.2018.01.003_bib1140","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/332411a0","article-title":"A novel potent vasoconstrictor peptide produced by vascular endothelial cells","volume":"332","author":"Yanagisawa","year":"1988","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.biocel.2018.01.003_bib1145","doi-asserted-by":"crossref","first-page":"5479","DOI":"10.1242\/jcs.02655","article-title":"NO-dependent osteoclast motility: reliance on cGMP-dependent protein kinase I and VASP","volume":"118","author":"Yaroslavskiy","year":"2005","journal-title":"J. Cell Sci."},{"issue":"7","key":"10.1016\/j.biocel.2018.01.003_bib1150","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.biocel.2018.01.003_bib1155","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/jcp.1041570312","article-title":"Plasminogen-dependent activation of latent transforming growth factor beta (TGF\u03b2) by growing cultures of osteoblast-like cells","volume":"157","author":"Yee","year":"1993","journal-title":"J. Cell. Physiol."},{"issue":"3","key":"10.1016\/j.biocel.2018.01.003_bib1160","first-page":"917","article-title":"Tumor-derived platelet-derived growth factor-BB plays a critical role in osteosclerotic bone metastasis in an animal model of human breast cancer","volume":"62","author":"Yi","year":"2002","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.biocel.2018.01.003_bib1165","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1172\/JCI28568","article-title":"The stem cell niches in bone","volume":"116","author":"Yin","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.biocel.2018.01.003_bib1170","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1172\/JCI3523","article-title":"TGF-\u03b2 signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development","volume":"103","author":"Yin","year":"1999","journal-title":"J. Clin. Invest."},{"issue":"19","key":"10.1016\/j.biocel.2018.01.003_bib1175","doi-asserted-by":"crossref","first-page":"10954","DOI":"10.1073\/pnas.1830978100","article-title":"A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases","volume":"100","author":"Yin","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"8","key":"10.1016\/j.biocel.2018.01.003_bib1180","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1359\/jbmr.2001.16.8.1486","article-title":"A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro","volume":"16","author":"Yoneda","year":"2001","journal-title":"J. Bone Miner. Res."},{"issue":"6274","key":"10.1016\/j.biocel.2018.01.003_bib1185","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/345442a0","article-title":"The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene","volume":"345","author":"Yoshida","year":"1990","journal-title":"Nature"},{"issue":"3a","key":"10.1016\/j.biocel.2018.01.003_bib1190","first-page":"1361","article-title":"Bone sialoprotein promotes bone metastasis of a non-bone-seeking clone of human breast cancer cells","volume":"24","author":"Zhang","year":"2004","journal-title":"Anticancer Res."},{"issue":"2","key":"10.1016\/j.biocel.2018.01.003_bib1195","doi-asserted-by":"crossref","first-page":"R37","DOI":"10.1186\/ar2391","article-title":"TNF inhibits production of stromal cell-derived factor 1 by bone stromal cells and increases osteoclast precursor mobilization from bone marrow to peripheral blood","volume":"10","author":"Zhang","year":"2008","journal-title":"Arthritis. Res. Ther."},{"issue":"1","key":"10.1016\/j.biocel.2018.01.003_bib1200","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ccr.2009.05.017","article-title":"Latent bone metastasis in breast cancer tied to Src-dependent survival signals","volume":"16","author":"Zhang","year":"2009","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.biocel.2018.01.003_bib1205","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3892\/ol.2011.487","article-title":"C-Src-mediated RANKL-induced breast cancer cell migration by activation of the ERK and Akt pathway","volume":"3","author":"Zhang","year":"2012","journal-title":"Oncology Letters"},{"issue":"7","key":"10.1016\/j.biocel.2018.01.003_bib1210","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1600-0463.2011.02864.x","article-title":"c-Src expression is predictive of poor prognosis in breast cancer patients with bone metastasis: but not in patients with visceral metastasis","volume":"120","author":"Zhang","year":"2012","journal-title":"APMIS"},{"issue":"5","key":"10.1016\/j.biocel.2018.01.003_bib1215","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2013.07.036","article-title":"Selection of bone metastasis seeds by mesenchymal signals in the primary tumor stroma","volume":"154","author":"Zhang","year":"2013","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.biocel.2018.01.003_bib1220","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1359\/JBMR.051204","article-title":"Pharmacological sequestration of intracellular cholesterol in late endosomes disrupts ruffled border formation in osteoclasts","volume":"21","author":"Zhao","year":"2006","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.biocel.2018.01.003_bib1225","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cmet.2006.05.012","article-title":"Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis","volume":"4","author":"Zhao","year":"2006","journal-title":"Cell Metab."},{"issue":"12","key":"10.1016\/j.biocel.2018.01.003_bib1230","doi-asserted-by":"crossref","first-page":"5821","DOI":"10.1158\/0008-5472.CAN-06-4499","article-title":"Tumor \u03b1v\u03b23 integrin is a therapeutic target for breast cancer bone metastases","volume":"67","author":"Zhao","year":"2007","journal-title":"Cancer Res."},{"issue":"19","key":"10.1016\/j.biocel.2018.01.003_bib1235","doi-asserted-by":"crossref","first-page":"9542","DOI":"10.1158\/0008-5472.CAN-07-1046","article-title":"Accelerated bone resorption: due to dietary calcium deficiency, promotes breast cancer tumor growth in bone","volume":"67","author":"Zheng","year":"2007","journal-title":"Cancer Res."},{"issue":"14","key":"10.1016\/j.biocel.2018.01.003_bib1240","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/onc.2010.543","article-title":"PTPH1 cooperates with vitamin D receptor to stimulate breast cancer growth through their mutual stabilization","volume":"30","author":"Zhi","year":"2011","journal-title":"Oncogene"}],"container-title":["The International Journal of Biochemistry &amp; Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272518300037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272518300037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T07:12:32Z","timestamp":1761203552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357272518300037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":248,"alternative-id":["S1357272518300037"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2018.01.003","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Breast cancer bone metastases: pathogenesis and therapeutic targets","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2018.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}